NO991827D0 - FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon - Google Patents

FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon

Info

Publication number
NO991827D0
NO991827D0 NO991827A NO991827A NO991827D0 NO 991827 D0 NO991827 D0 NO 991827D0 NO 991827 A NO991827 A NO 991827A NO 991827 A NO991827 A NO 991827A NO 991827 D0 NO991827 D0 NO 991827D0
Authority
NO
Norway
Prior art keywords
procedure
treatment
streptococcus pneumoniae
pneumoniae infection
infection
Prior art date
Application number
NO991827A
Other languages
English (en)
Other versions
NO991827L (no
Inventor
Beth P Goldstein
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of NO991827L publication Critical patent/NO991827L/no
Publication of NO991827D0 publication Critical patent/NO991827D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO991827A 1996-10-18 1999-04-16 FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon NO991827D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2881296P 1996-10-18 1996-10-18
PCT/US1997/018904 WO1998017303A1 (en) 1996-10-18 1997-10-14 A method for the treatment of streptococcus pneumoniae infection

Publications (2)

Publication Number Publication Date
NO991827L NO991827L (no) 1999-04-16
NO991827D0 true NO991827D0 (no) 1999-04-16

Family

ID=21845562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991827A NO991827D0 (no) 1996-10-18 1999-04-16 FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon

Country Status (13)

Country Link
US (1) US5910479A (no)
JP (1) JP2001506976A (no)
KR (1) KR20000049199A (no)
CN (1) CN1233186A (no)
AU (1) AU4909497A (no)
BR (1) BR9712633A (no)
CA (1) CA2264794A1 (no)
HU (1) HUP0000146A2 (no)
IL (1) IL128849A0 (no)
NO (1) NO991827D0 (no)
PL (1) PL332690A1 (no)
WO (1) WO1998017303A1 (no)
ZA (1) ZA979110B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
CA2508796A1 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
WO2009141264A2 (en) * 2008-05-20 2009-11-26 Boehringer Ingelheim Vetmedica Gmbh Gallidermin to treat infections of the respiratory tract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4548924A (en) * 1984-04-16 1985-10-22 Eli Lilly And Company Antibiotics M43B and M43C, pharmaceutical composition and method of use
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
GB8811760D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Antibiotic
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
IN167138B (no) * 1988-08-17 1990-09-01 Hoechst India
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
FR2664894A1 (fr) * 1990-07-19 1992-01-24 Rhone Poulenc Sante Nouveaux derives de streptogramines et leur preparation.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
US5866539A (en) * 1995-06-23 1999-02-02 Ambi Inc. Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection

Also Published As

Publication number Publication date
JP2001506976A (ja) 2001-05-29
HUP0000146A2 (hu) 2000-06-28
US5910479A (en) 1999-06-08
PL332690A1 (en) 1999-09-27
WO1998017303A1 (en) 1998-04-30
NO991827L (no) 1999-04-16
ZA979110B (en) 1998-05-11
IL128849A0 (en) 2000-01-31
BR9712633A (pt) 1999-12-21
CA2264794A1 (en) 1998-04-30
KR20000049199A (ko) 2000-07-25
AU4909497A (en) 1998-05-15
CN1233186A (zh) 1999-10-27

Similar Documents

Publication Publication Date Title
NO984431L (no) FremgangsmÕte for behandling av smerte
DE69530610D1 (de) Medizinisches thermometer
NO991381D0 (no) Kombinasjonsterapi for behandling av psykoser
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20003042L (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO970668L (no) Fremgangsmåte for fremstilling av peroksidholdig perfluorpolyoxyalkylener
NO20010953D0 (no) En fremgangsmÕte for behandling av stafylokokkal sykdom
FI964572A0 (fi) Prosessi propeenin homo- tai kopolymeerien valmistProsessi propeenin homo- tai kopolymeerien valmistamiseksi amiseksi
NO984446D0 (no) FremgangsmÕte for behandling av smerte
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO991827D0 (no) FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
FI951655A0 (fi) H.pylori -infektioiden hoito
NO984905D0 (no) FremgangsmÕte for fremstilling av b°rstevarer
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO982562D0 (no) Sammensetning for behandling av smerte
NO991158D0 (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO20015291D0 (no) Månedlig dose for behandling av streptokokkus pneumoniaeinfeksjoner
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application